Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Sentz

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Plasma pharmacokinetics and urinary excretion of the polyamine analogue 1, 19-bis(ethylamino)-5, 10, 15-triazanonadecane in CD2F1 miceJ L Eiseman, Z M Yuan, N D Eddington, et al.
Cancer Chemotherapy and Pharmacology|September 6, 2000
Pharmacokinetics and antitumor properties in tumor-bearing mice of an enediol analogue inhibitor of glyoxalase IE M Sharkey, H B O'Neill, M J Kavarana, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Plasma pharmacokinetics, bioavailability, and tissue distribution in CD2F1 mice of halomon, an antitumor halogenated monoterpene isolated from the red algae Portieria hornemanniiM J Egorin, D L Sentz, D M Rosen, et al.
Cancer Research|November 11, 1998
Tumor-targeted apoptosis by a novel spermine analogue, 1,12-diaziridinyl-4,9-diazadodecane, results in therapeutic efficacy and enhanced radiosensitivity of human prostate cancerJ L Eiseman, F A Rogers, Y Guo, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Plasma pharmacokinetics and tissue distribution of paclitaxel in CD2F1 miceJ L Eiseman, N D Eddington, J Leslie, et al.
Journal of Medicinal Chemistry|January 5, 1996
Synthesis and antitumor evaluation of a highly potent cytotoxic DNA cross-linking polyamine analogue, 1,12-diaziridinyl-4,9-diazadodecaneY Li, J L Eiseman, D L Sentz, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Plasma pharmacokinetics and urinary excretion of the polyamine analogue 1, 19-bis(ethylamino)-5, 10, 15-triazanonadecane in CD2F1 miceJ L Eiseman, Z M Yuan, N D Eddington, et al.
Cancer Chemotherapy and Pharmacology|September 6, 2000
Pharmacokinetics and antitumor properties in tumor-bearing mice of an enediol analogue inhibitor of glyoxalase IE M Sharkey, H B O'Neill, M J Kavarana, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Plasma pharmacokinetics, bioavailability, and tissue distribution in CD2F1 mice of halomon, an antitumor halogenated monoterpene isolated from the red algae Portieria hornemanniiM J Egorin, D L Sentz, D M Rosen, et al.
Cancer Research|November 11, 1998
Tumor-targeted apoptosis by a novel spermine analogue, 1,12-diaziridinyl-4,9-diazadodecane, results in therapeutic efficacy and enhanced radiosensitivity of human prostate cancerJ L Eiseman, F A Rogers, Y Guo, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Plasma pharmacokinetics and tissue distribution of paclitaxel in CD2F1 miceJ L Eiseman, N D Eddington, J Leslie, et al.
Journal of Medicinal Chemistry|January 5, 1996
Synthesis and antitumor evaluation of a highly potent cytotoxic DNA cross-linking polyamine analogue, 1,12-diaziridinyl-4,9-diazadodecaneY Li, J L Eiseman, D L Sentz, et al.
Pageof 2